Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
 
Sign in
Join now
featured
Published in Von Hippel-Lindau Disease and
1 other channel

Expert Opinion / Interview · October 11, 2021

Belzutifan FDA Approval for VHL-Associated Cancers

Elshad Hasanov MD, PhD
Eric Jonasch MD
Interview with
Eric Jonasch MD

 

 Save  Recommend
 Share

Additional Info

Disclosure statements are available on the authors' profiles:

Elshad Hasanov MD, PhD

Eric Jonasch MD

Further Reading

Related Videos